RecruitingPhase 3NCT06497465
Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Ethel M Weld, MDJohns Hopkins University
- Intervention
- Dolutegravir 50mg Tab(drug)
- Enrollment
- 150 enrolled
- Eligibility
- 15-99 years · All sexes
- Timeline
- 2025 – 2029
Study locations (6)
- Instituto Tropical de Doenças Infecciosas Manaus, Manaus, Amazonas, Brazil
- Universidade Federal da Bahia, Salvador, Estado de Bahia, Brazil
- FIOCruz, Rio de Janeiro, Rio de Janeiro, Brazil
- Hospital Geral de Nova Iguaçu, Rio de Janeiro, Rio de Janeiro, Brazil
- CePClin - Center for Studies and Research in Infectious Diseases Ltda, Natal, Rio Grande do Norte, Brazil
- RDSS- Ricardo Diaz Solucoes Cientificas, São Paulo, São Paulo, Brazil
Collaborators
ViiV Healthcare
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06497465 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine
- RECRUITINGPHASE3NCT07152639Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and AboveChengdu CoenBiotech Co., Ltd